Vascular Medicine News

An intervention reduced daily sitting time and systolic BP among older adults, according to results of a randomized controlled trial published in JAMA Network Open.

Among individuals with darker skin tones, pulse oximeters often overestimated their oxygen saturation levels, according to a systematic review published in British Journal of Anaesthesia.

Daily sodium intake above the recommended amount increased the risk for mortality from CVD and heart failure among historically underrepresented and underserved populations, a study showed.

Treating psoriasis with oral roflumilast may induce weight loss, positioning the drug as a potentially attractive alternative for patients with psoriasis, according to a study.

The FDA has approved sotatercept, an activin signaling inhibitor, for treating adults with pulmonary arterial hypertension, according to a manufacturer-issued press release.

“Knowledge and understanding of what preeclampsia can do during and after pregnancy and birth is critical.”

Environmental injustices such as air pollution and poor transport infrastructure may play a significant role in regional risk for cardiovascular disease and risk factors for it, researchers reported.

Elixir Medical announced it received breakthrough device designation FDA for its novel adaptive implant for the treatment of narrowed or blocked below-the-knee vessels in patients with chronic limb-threatening ischemia.

The FDA has approved Opsynvi, a once-daily tablet that includes both macitentan and tadalafil, to treat adults with pulmonary arterial hypertension, according to a manufacturer-issued press release.

Upfront combination therapy for patients with low-risk pulmonary arterial hypertension was not significantly better than monotherapy when assessing time to clinical worsening, according to results published in CHEST.